BioNTech to provide 50 million needles to extract more vaccine doses

Hello and welcome to the details of BioNTech to provide 50 million needles to extract more vaccine doses and now with the details

The vaccine from BioNTech and US partner Pfizer was initially sold in the EU in vials meant to deliver five doses, but a global shortage of shots and a viability assessment on dosage convinced the EU drugs regulator to approve on January 8 the extraction of six doses from the same vials. — Reuters pic
Nevin Al Sukari - Sana'a - The vaccine from BioNTech and US partner Pfizer was initially sold in the EU in vials meant to deliver five doses, but a global shortage of shots and a viability assessment on dosage convinced the EU drugs regulator to approve on January 8 the extraction of six doses from the same vials. — Reuters pic

FRANKFURT, Jan 22 — BioNTech is to supply 50 million specialty needles at no profit to countries struggling to extract a sixth dose from vials of its Covid-19 vaccine, while Europe’s immunisation campaign is hampered by a temporary supply shortfall.

European Union countries have been rushing to secure supplies of special syringes with so-called low dead space that are needed to stop any vaccine being wasted when shots are administered.

“BioNTech purchased low dead space needles which work with multiple syringes and is offering a supply with the low dead space needles to countries around the world on a cost-covering basis,” it said in a written statement to Reuters.

The vaccine from BioNTech and US partner Pfizer was initially sold in the EU in vials meant to deliver five doses, but a global shortage of shots and a viability assessment on dosage convinced the EU drugs regulator to approve on January 8 the extraction of six doses from the same vials.

The decision increased availability, prompting Pfizer to raise its output targets for this year to two billion vaccines from 1.3 billion initially envisaged.

Yet some European countries have been drawing fewer than the approved six doses because they lack the right injection equipment.

Officials and healthcare professionals in France, Germany and Switzerland this week all pointed to lower yields, adding to frustrations in countries already lagging vaccination campaigns in countries such as Britain and the United States.

Pfizer, in a separate statement, said it was in talks with the European Commission and EU member states “on how we can best support vaccinations plans — this includes supporting governments in securing supply of (low-dead-space) syringes should they need it.”

BioNTech, headquartered in Mainz, Germany, said it had taken delivery of around 50 million such needles, which it could provide to countries around the world, and was in talks to procure more. — Reuters

These were the details of the news BioNTech to provide 50 million needles to extract more vaccine doses for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.

It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.

PREV Three students shot dead, eight people wounded at Michigan high school; suspect arrested
NEXT Pope visits divided Cyprus, eyes on migrants